Functional Proteomics And Nanotechnology-Based Microarrays

NICOLINI C.

ISBN 10: 9814267767 / ISBN 13: 9789814267762

Editore: PAN STANFORD PUBLISHING, 2010

Riguardo questo articolo

Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 7-11 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India,& United states & United Kingdom. Depending on your location and availability.

Codice articolo CBS 9789814267762

Dati bibliografici

• Titolo: Functional Proteomics And Nanotechnology-Based Microarrays
• Editore: PAN STANFORD PUBLISHING
• Data di pubblicazione: 2010
• Lingua: Inglese
• ISBN 10: 9814267767
• ISBN 13: 9789814267762
• Rilegatura: Rilegato
• Edizione: Edizione Internazionale
• Condizione: Brand New

Descrizione articolo

Riassunto

This volume introduces in a coherent and comprehensive fashion the Pan Stanford Series on Nanobiobiotechnology by defining and reviewing the major sectors of Nanobiotechnology and Nanobiosciences with respect to the most recent developments. Nanobiotechnology indeed appears capable of yielding a scientific and industrial revolution along the routes correctly foreseen by the numerous programs on Nanotechnology launched over the last decade by numerous Councils and Governments worldwide, beginning in the late 1995 by the Science and Technology Council in Italy and by the President Clinton in USA and ending this year with President Putin in Russian Federation.

Informazioni sull?autore

Dr. Joshua LaBaer is one of the nation’s foremost investigators in the rapidly expanding field of personalized medicine. Formerly director of the Harvard Institute of Proteomics (HIP), he was recently recruited to ASU’s Biodesign Institute as the first Piper Chair in Personalized Medicine.

Dr. LaBaer’s efforts involve leveraging the Center’s formidable resources for the discovery and validation of biomarkers―unique molecular fingerprints of disease―which can provide early warning for those at risk of major illnesses, including cancer and diabetes. This work is carried out in conjunction with the Partnership for Personalized Medicine, a multi-institution effort that includes the Translational Genomics Research Institute (TGen) in Phoenix and the Fred Hutchinson Cancer Research Institute in Seattle.

Dr. LaBaer completed his internship and residency at the Brigham and Women’s Hospital and a clinical fellowship in Oncology at the Dana-Farber Cancer Institute, both in Boston. He is a board certified physician in Internal Medicine and Medical Oncology and was an Instructor and Clinical Fellow in Medicine at Harvard Medical School. He has contributed more than 60 original research publications, reviews and chapters. Dr. LaBaer is an associate editor of the Journal of Proteome Research, Analytical Biochemistry, and a member of the Scientific Advisory Boards for the Proteome Society, Promega Corporation, Lumera-Plexera Corporation, Barnett Institute, and a founding member of the Human Proteome Organization.